Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Feeding Behavior 1 Colorectal Neoplasms 1

Interventions

Oxaliplatin 1439 Fluorouracil 1319 Capecitabine 1115 Gemcitabine 1058 Leucovorin 939 Bevacizumab 847 Irinotecan 830 Cisplatin 678 Radiotherapy 560 Cetuximab 482 pembrolizumab 437 Paclitaxel 401 Drug Therapy 358 Nivolumab 350 130-nm albumin-bound paclitaxel 329 Docetaxel 290 Sorafenib 288 S 1 (combination) 280 Folfox protocol 266 Albumin-Bound Paclitaxel 263 Surgical Procedures, Operative 258 lenvatinib 223 sintilimab 218 tislelizumab 214 durvalumab 212 regorafenib 209 Magnetic Resonance Spectroscopy 205 apatinib 204 Radiosurgery 204 Carboplatin 191

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Matrilin Proteins × Gastrointestinal × Clear all

NCT04753359 2026-05-27

Bridge CRC

University of Illinois at Chicago

Phase NA Completed

Gastrointestinal

Feeding Behavior, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡